Literature DB >> 284396

Self-catalyzed destruction of cytochrome P-450: covalent binding of ethynyl sterols to prosthetic heme.

P R Ortiz de Montellano, K L Kunze, G S Yost, B A Mico.   

Abstract

The hepatic pigment accumulated as a consequence of the self-catalyzed destruction of cytochrome P-450 by norethisterone (17-hydroxy-19-nor-17 alpha-pregn-4-en-20-yn-3-one), after acidic methylation and purification, consists of two virtually identical, probably isomeric, porphyrins. Radiolabeled norethisterone is incorporated into both porphyrin products. The major of the two porphyrins exhibits a mass spectrometric molecular ion exactly equivalent to the sum of norethisterone and dimethylprotoporphyrin IX, less two hydrogen atoms: unequivocably demonstrating covalent association of the sterol with this porphyrin in a 1:1 ratio. Cytochrome P-450 is therefore destroyed by self-catalyzed addition of norethisterone to its heme prosthetic group. Cytochrome P-450 is also destroyed by norgestrel (13-ethyl-17-hydroxyl-18, 19-dinor-17 alpha-pregn-4-en-20-yn-3-one) and by 1-ethynylcyclohexanol but not by 17-hydroxy-19-nor-17alpha-pregn-4,20-dien-3-one. The destructive potential is thus clearly a property of the propargylic alcohol function. A mechanism involving enzymatic oxidation of the triple bond is postulated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284396      PMCID: PMC383038          DOI: 10.1073/pnas.76.2.746

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Degradation of hepatic haem to porphyrins and oxophlorins in rats treated with 2-allyl-2-isopropylacetamide.

Authors:  A F McDonagh; R Pospisil; U A Meyer
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.

Authors:  I N White; U Muller-Eberhard
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

4.  The excretion of tritium-labeled chlormadinone acetate, mestranol, norethindrone, and norethynodrel in rats and the enterohepatic circulation of metabolites.

Authors:  G K Hanasono; L J Fischer
Journal:  Drug Metab Dispos       Date:  1974 Mar-Apr       Impact factor: 3.922

5.  Metabolism of 17-alpha-ethynylestradiol and its 3-methyl ether by the rabbit; an in vivo D-homoannulation.

Authors:  M T Abdel-Aziz; K I Williams
Journal:  Steroids       Date:  1969-06       Impact factor: 2.668

Review 6.  Increased liver haem degradation caused by foreign chemicals: a comparison of the effects of 2-allyl-2-isopropylacetamide and cobaltous chloride.

Authors:  F De Matteis; A Unseld
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

7.  Suicidal inactivation of cytochrome P-450. Formation of a heme-substrate covalent adduct.

Authors:  P R Ortiz de Montellano; B A Mico; G S Yost
Journal:  Biochem Biophys Res Commun       Date:  1978-07-14       Impact factor: 3.575

8.  Breakdown of cytochrome P-450 heme by secobarbital and other allyl-containing barbiturates.

Authors:  W Levin; M Jacobson; E Sernatinger; R Kuntzman
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

9.  Drug-induced destruction of cytochrome P-450.

Authors:  F De Matteis
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

10.  Stereoselective biotransformations of dl-norgestrel and its enantiomers in the African green monkey.

Authors:  S F Sisenwine; H B Kimmel; A L Liu; H W Ruelius
Journal:  Drug Metab Dispos       Date:  1974 Jan-Feb       Impact factor: 3.922

View more
  19 in total

Review 1.  Rearrangement reactions catalyzed by cytochrome P450s.

Authors:  Paul R Ortiz de Montellano; Sidney D Nelson
Journal:  Arch Biochem Biophys       Date:  2010-10-29       Impact factor: 4.013

Review 2.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Heme and I.

Authors:  Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

Review 4.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 5.  Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.

Authors:  Paul R Ortiz de Montellano
Journal:  Drug Metab Rev       Date:  2019-07-07       Impact factor: 4.518

6.  Drug-induced conversion of liver haem into modified porphyrins. Evidence for two classes of products.

Authors:  F De Matteis; A H Gibbs
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

7.  Haem control in experimental porphyria. The effect of haemin on the induction of delta-aminolaevulinate synthase in isolated chick-embryo liver cells.

Authors:  G Srivastava; J D Brooker; B K May; W H Elliott
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

8.  Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor.

Authors:  F De Matteis; A H Gibbs; T R Tephly
Journal:  Biochem J       Date:  1980-04-15       Impact factor: 3.857

9.  Epoxidation of olefins by cytochrome P-450 model compounds: mechanism of oxygen atom transfer.

Authors:  J P Collman; J I Brauman; B Meunier; S A Raybuck; T Kodadek
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Incorporation of haemoglobin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450.

Authors:  J F Wyman; J L Gollan; W Settle; G C Farrell; M A Correia
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.